SNOA - Sonoma Pharmaceuticals Inc Options

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: KALA SPRO TNXP PALI SHPH

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.04	Insider Own	1.21%	Shs Outstand	1.73M	Perf Week	0.00%
Market Cap	2.09M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.72M	Perf Month	-50.21%
Enterprise Value	0.19M	PEG	-	EPS next Q	-	Inst Own	6.25%	Short Float	0.94%	Perf Quarter	-60.40%
Income	-3.37M	P/S	0.12	EPS this Y	-	Inst Trans	1.32%	Short Ratio	0.10	Perf Half Y	-68.09%
Sales	17.72M	P/B	0.61	EPS next Y	-	ROA	-24.70%	Short Interest	0.02M	Perf YTD	-67.03%
Book/sh	1.98	P/C	0.82	EPS next 5Y	-	ROE	-81.19%	52W High	6.92 -82.66%	Perf Year	-62.62%
Cash/sh	1.47	P/FCF	-	EPS past 3/5Y	58.27% 42.62%	ROIC	-85.51%	52W Low	0.85 41.16%	Perf 3Y	-93.95%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	4.20% -4.44%	Gross Margin	38.16%	Volatility	5.63% 10.83%	Perf 5Y	-99.19%
Dividend TTM	-	EV/Sales	0.01	EPS Y/Y TTM	48.18%	Oper. Margin	-15.61%	ATR (14)	0.18	Perf 10Y	-99.87%
Dividend Ex-Date	-	Quick Ratio	1.97	Sales Y/Y TTM	26.83%	Profit Margin	-19.02%	RSI (14)	32.50	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.84	EPS Q/Q	24.58%	SMA20	-26.61%	Beta	1.29	Target Price	12.00
Payout	-	Debt/Eq	0.19	Sales Q/Q	22.03%	SMA50	-43.10%	Rel Volume	0.54	Prev Close	1.18
Employees	168	LT Debt/Eq	0.15	Earnings	Feb 10 BMO	SMA200	-63.66%	Avg Volume	158.79K	Price	1.20
IPO	Jan 25, 2007	Option/Short	No / Yes	EPS/Sales Surpr.	-21.24% -20.55%	Trades		Volume	86,027	Change	1.69%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)